Outlook Therapeutics, Inc.
BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES

Abstract:

The invention provides buffered aqueous formulations of bevacizumab. The invention further provides methods of making buffered formulations of bevacizumab. The invention provides methods of treating eye disorders, particularly wet age-related macular degeneration and macular edema by administering the buffered antibody compositions of the disclosure.